Blirt S.A.-Product Pipeline Review-2015
Global Markets Direct's, 'Blirt S.A.-Product Pipeline Review-2015', provides an overview of the Blirt S.A.'s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Blirt S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
The report provides brief overview of Blirt S.A. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Blirt S.A.'s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Blirt S.A.'s pipeline products
Reasons To Buy
Evaluate Blirt S.A.'s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Blirt S.A. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Blirt S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Blirt S.A. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Blirt S.A.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Blirt S.A. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Blirt S.A. Snapshot 4
Blirt S.A. Overview 4
Key Information 4
Key Facts 4
Blirt S.A.-Research and Development Overview 5
Key Therapeutic Areas 5
Blirt S.A.-Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products-Monotherapy 8
Blirt S.A.-Pipeline Products Glance 9
Blirt S.A.-Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Blirt S.A.-Drug Profiles 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Product Description 11
Mechanism of Action 11
R&D Progress 11
Product Description 12
Mechanism of Action 12
R&D Progress 12
Blirt S.A.-Pipeline Analysis 13
Blirt S.A.-Pipeline Products by Target 13
Blirt S.A.-Pipeline Products by Molecule Type 14
Blirt S.A.-Pipeline Products by Mechanism of Action 15
Blirt S.A.-Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Secondary Research 17
Primary Research 17
Expert Panel Validation 17
Contact Us 17
List of Tables
Blirt S.A., Key Information 4
Blirt S.A., Key Facts 4
Blirt S.A.-Pipeline by Indication, 2015 6
Blirt S.A.-Pipeline by Stage of Development, 2015 7
Blirt S.A.-Monotherapy Products in Pipeline, 2015 8
Blirt S.A.-Preclinical, 2015 9
Blirt S.A.-Pipeline by Target, 2015 13
Blirt S.A.-Pipeline by Molecule Type, 2015 14
Blirt S.A.-Pipeline Products by Mechanism of Action, 2015 15
Blirt S.A., Other Locations 16
Blirt S.A., Subsidiaries 16
List of Figures
Blirt S.A.-Pipeline by Top 10 Indication, 2015 6
Blirt S.A.-Pipeline by Top 10 Target, 2015 13
Blirt S.A.-Pipeline Products by Top 10 Mechanism of Action, 2015 15
Single User License:
Corporate User License:
Current R&D Portfolio of Blirt S.A.; Blirt S.A. - Key Therapeutics; Blirt S.A. - Pipeline Overview and Promising Molecules; Blirt S.A. - News; Blirt S.A. - Latest Updates; Blirt S.A. - Pipeline; Blirt S.A. - Discontinued/Dormant Projects
select a license
NEWSLETTER BY CATEGORY
An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ... "General Manager SBU Manufacture, PT. KIMIA FARMA, TBK"
Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process.... "VP Innovation, Engineered Profiles LLC"
Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed... "President, VPP E-Data Services, VPP E-Data Services"
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"